Speaker(s): 

Sabrina Steed, OD, FAAO, Geisinger Staff Member - has nothing to disclose.

Moderator(s): 

David Mallarkey, BSN, RN, Geisinger Staff Member - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe the pathophysiological mechanisms by which diabetes affects ocular structures, including the retina, lens, and optic nerve.
• Identify the key clinical manifestations of diabetic eye disease, such as diabetic retinopathy, diabetes macular edema, cataracts, and neurovascular glaucoma.
• Differentiate between the stages of diabetic retinopathy (non-proliferative and proliferative) based on clinical and imaging findings
• Explain the role of systemic factors (e.g., glycemic control, hypertension, lipid levels) in the progression of diabetic eye disease.
• Interpret common diagnostic tools used in the assessment of diabetic eye complications, including fundus photography, OCT, and fluorescein angiography.
• Discuss current management strategies for diabetic eye disease, including pharmacologic treatments (e.g., anti-VEGF therapy), laser therapy, and surgical interventions.
• Evaluate preventive strategies for diabetic eye disease, including the importance of regular screening and early intervention.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Stacy Coolbaugh, MBA, RDN, LDN; Angela Marino, RDN, LDN, CDCES; Adriene Zook, PharmD, RPH; David Mallarkey, BSN, RN, Jaime Ruiz, RN, BSN, and Joey Underhill have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose.

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None